| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Acerus Pharmaceuticals Corporation (TO: ASP)
ASP Technical Analysis
2.5
| As on 1st Mar 2023 ASP STOCK Price closed @ 0.36 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.67 & Strong Buy for SHORT-TERM with Stoploss of 0.04 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ASPSTOCK Price
| Open | 0.36 | Change | Price | % |
| High | 0.36 | 1 Day | 0.00 | 0.00 |
| Low | 0.36 | 1 Week | 0.00 | 0.00 |
| Close | 0.36 | 1 Month | 0.08 | 28.57 |
| Volume | N/A | 1 Year | 0.31 | 620.00 |
| 52 Week High 6.28 | 52 Week Low 0.02 | ||||
TO Canada Most Active Stocks
| YRI | 7.89 | 0.13% |
| UEX | 0.50 | 16.28% |
| RY | 172.33 | % |
| CVE | 22.94 | % |
| BNS | 72.78 | % |
| TD | 77.32 | % |
| SJR-B | 40.48 | 0.02% |
| BMO | 129.54 | % |
| MFC | 41.89 | % |
| FCU | 0.92 | % |
TO Canada Top Gainers Stocks
TO Canada Top Losers Stocks
| ASP Daily Charts |
ASP Intraday Charts |
Whats New @ Bazaartrend |
ASP Free Analysis |
|
|
ASP Important Levels Intraday
| RESISTANCE | 0.36 |
| RESISTANCE | 0.36 |
| RESISTANCE | 0.36 |
| RESISTANCE | 0.36 |
| RESISTANCE | 0.36 |
| RESISTANCE | 0.36 |
| RESISTANCE | 0.36 |
| RESISTANCE | 0.36 |
ASP Forecast October 2024
| 4th UP Forecast | 0.38 |
| 3rd UP Forecast | 0.37 |
| 2nd UP Forecast | 0.37 |
| 1st UP Forecast | 0.37 |
| 1st DOWN Forecast | 0.35 |
| 2nd DOWN Forecast | 0.35 |
| 3rd DOWN Forecast | 0.35 |
| 4th DOWN Forecast | 0.34 |
ASP Weekly Forecast
| 4th UP Forecast | 0.36 |
| 3rd UP Forecast | 0.36 |
| 2nd UP Forecast | 0.36 |
| 1st UP Forecast | 0.36 |
| 1st DOWN Forecast | 0.36 |
| 2nd DOWN Forecast | 0.36 |
| 3rd DOWN Forecast | 0.36 |
| 4th DOWN Forecast | 0.36 |
ASP Forecast2024
| 4th UP Forecast | 13.12 |
| 3rd UP Forecast | 9.03 |
| 2nd UP Forecast | 6.5 |
| 1st UP Forecast | 3.97 |
| 1st DOWN Forecast | -3.25 |
| 2nd DOWN Forecast | -5.78 |
| 3rd DOWN Forecast | -8.31 |
| 4th DOWN Forecast | -12.4 |
Acerus Pharmaceuticals Corporation ( TO Canada Symbol : ASP )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ASP Business Profile
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; Estrace, an oral tablet for the symptomatic relief of menopausal symptoms; and UriVarx, a natural health product that helps reduce symptoms of hyperactive bladder, such as daytime urinary frequency, urgency, and nocturia. It also engages in developing Lidbree, a short acting lidocaine formulation delivered through a proprietary device into the vaginal mucosal tissue; Stendra, a PDE5 inhibitor for the treatment of erectile dysfunction; Elegant vaginal moisturizer, which provides comfort to women suffering from vaginal dryness; and Elegant pH, a pH balanced vaginal product; and Tefina, a clinical stage product for women with female sexual dysfunction. In addition, the company provides TriVair technology platform for pulmonary and nasal dosing. Acerus Pharmaceuticals Corporation sells products through its salesforce in the United States; and through a network of distributors internationally. The company was formerly known as Trimel Pharmaceuticals Corporation and changed its name to Acerus Pharmaceuticals Corporation in September 2015. Acerus Pharmaceuticals Corporation was founded in 2008 and is headquartered in Mississauga, Canada. Address: 7025 Langer Drive, Mississauga, ON, Canada, L5N 0E8
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service